220 related articles for article (PubMed ID: 8438569)
1. Morphogenic capabilities of human immunodeficiency virus type 1 gag and gag-pol proteins in insect cells.
Hughes BP; Booth TF; Belyaev AS; McIlroy D; Jowett J; Roy P
Virology; 1993 Mar; 193(1):242-55. PubMed ID: 8438569
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles.
Karacostas V; Wolffe EJ; Nagashima K; Gonda MA; Moss B
Virology; 1993 Apr; 193(2):661-71. PubMed ID: 7681610
[TBL] [Abstract][Full Text] [Related]
3. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
[TBL] [Abstract][Full Text] [Related]
5. Contribution of the Gag-Pol transframe domain p6* and its coding sequence to morphogenesis and replication of human immunodeficiency virus type 1.
Paulus C; Ludwig C; Wagner R
Virology; 2004 Dec; 330(1):271-83. PubMed ID: 15527852
[TBL] [Abstract][Full Text] [Related]
6. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V
Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902
[TBL] [Abstract][Full Text] [Related]
7. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
Kang CY; Luo L; Wainberg MA; Li Y
Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
[TBL] [Abstract][Full Text] [Related]
8. The virus-associated human immunodeficiency virus type 1 Gag-Pol carrying an active protease domain in the matrix region is severely defective both in autoprocessing and in trans processing of gag particles.
Chen SW; Chiu HC; Liao WH; Wang FD; Chen SS; Wang CT
Virology; 2004 Jan; 318(2):534-41. PubMed ID: 14972522
[TBL] [Abstract][Full Text] [Related]
9. Assembly of the matrix protein of simian immunodeficiency virus into virus-like particles.
González SA; Affranchino JL; Gelderblom HR; Burny A
Virology; 1993 Jun; 194(2):548-56. PubMed ID: 8503172
[TBL] [Abstract][Full Text] [Related]
10. The role of nucleocapsid of HIV-1 in virus assembly.
Dawson L; Yu XF
Virology; 1998 Nov; 251(1):141-57. PubMed ID: 9813210
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles.
Park J; Morrow CD
Virology; 1993 Jun; 194(2):843-50. PubMed ID: 8503189
[TBL] [Abstract][Full Text] [Related]
12. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
[TBL] [Abstract][Full Text] [Related]
13. [Expression and characterization of HIV-1 Gag p17-p24 protein].
Li TY; Jin NY; Wang HW; Guo ZR; Fang HH; An RG; Yin Z
Sheng Wu Gong Cheng Xue Bao; 2000 Jan; 16(1):65-8. PubMed ID: 10883279
[TBL] [Abstract][Full Text] [Related]
14. Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.
Liao WH; Wang CT
Virology; 2004 Nov; 329(1):180-8. PubMed ID: 15476885
[TBL] [Abstract][Full Text] [Related]
15. Differential budding efficiencies of human T-cell leukemia virus type I (HTLV-I) Gag and Gag-Pro polyproteins from insect and mammalian cells.
Bouamr F; Garnier L; Rayne F; Verna A; Rebeyrotte N; Cerutti M; Mamoun RZ
Virology; 2000 Dec; 278(2):597-609. PubMed ID: 11118382
[TBL] [Abstract][Full Text] [Related]
16. Cotransfection of mutated forms of human immunodeficiency virus type 1 Gag-Pol with wild-type constructs can interfere with processing and viral replication.
Morin N; Cherry E; Li X; Wainberg MA
J Hum Virol; 1998; 1(3):240-7. PubMed ID: 10195247
[TBL] [Abstract][Full Text] [Related]
17. [Formation of virus-like particles by HIV-1 Gag proteins, expressed by a recombinant vaccinia virus].
Vzorov AN; Tentsov IuIu; Grigor'ev VB; Shulenin SA; Garaev MM; Bogdan OP; Bukrinskaia AG
Mol Biol (Mosk); 1990; 24(6):1666-74. PubMed ID: 2094814
[TBL] [Abstract][Full Text] [Related]
18. Clustered epitopes within the Gag-Pol fusion protein DNA vaccine enhance immune responses and protection against challenge with recombinant vaccinia viruses expressing HIV-1 Gag and Pol antigens.
Bolesta E; Gzyl J; Wierzbicki A; Kmieciak D; Kowalczyk A; Kaneko Y; Srinivasan A; Kozbor D
Virology; 2005 Feb; 332(2):467-79. PubMed ID: 15680412
[TBL] [Abstract][Full Text] [Related]
19. Morphopoietic determinants of HIV-1 Gag particles assembled in baculovirus-infected cells.
Gay B; Tournier J; Chazal N; Carrière C; Boulanger P
Virology; 1998 Aug; 247(2):160-9. PubMed ID: 9705909
[TBL] [Abstract][Full Text] [Related]
20. Amino acid insertions near Gag cleavage sites restore the otherwise compromised replication of human immunodeficiency virus type 1 variants resistant to protease inhibitors.
Tamiya S; Mardy S; Kavlick MF; Yoshimura K; Mistuya H
J Virol; 2004 Nov; 78(21):12030-40. PubMed ID: 15479842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
